Nintedanib in Patients With Systemic Sclerosis Associated Interstitial Lung Disease: A Japanese Population Analysis of the SENSCIS Trial
Modern Rheumatology - United Kingdom
doi 10.1080/14397595.2020.1751402
Full Text
Open PDFAbstract
Available in full text
Date
April 23, 2020
Authors
Publisher
Informa UK Limited